Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2013
10/15/2013US8557601 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
10/15/2013CA2735294C N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b
10/15/2013CA2697256C Cyclopropyl amide derivatives
10/15/2013CA2522319C N-[(piperazinyl)hetaryl]arylsulfonamide compounds and derivatives thereof with affinity for the dopamine d3 receptor
10/10/2013WO2013151958A1 Process for preparing alkali metal pyrithione and its polyvalent metal complexes from pyridine oxide
10/10/2013WO2013151161A1 Novel compound, method for producing same and antitumor agent
10/10/2013WO2013150090A1 Nicotinamide powder and process and device for its production
10/10/2013WO2013111163A3 Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
10/10/2013US20130267702 Ampk-activating heterocyclic compounds and methods for using the same
10/10/2013US20130267701 Ampk-activating heterocyclic compounds and methods for using the same
10/10/2013US20130267565 4- (methylaminophenoxy) pyrdin -3- yl - benzamide derivatives for treating cancer
10/10/2013US20130267546 Multifunctional Radical Quenchers and Their Uses
10/10/2013US20130267536 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for production and use thereof
10/10/2013US20130267516 Substituted cyclopentyl-azines as casr-active compounds
10/10/2013US20130267492 Aryl sulfonamides
10/09/2013EP2647617A1 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
10/09/2013EP2646416A2 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
10/09/2013CN103347858A Method and substance for preparation of n-substituted pyridinium compounds
10/09/2013CN103347844A Method for producing ss-fluoroalcohol
10/09/2013CN103347510A Lysophosphatidic acid receptor antagonists and uses thereof
10/09/2013CN103342678A Aromatic diamine containing triphenylpyridine and tertiary butyl, soluble polyimide prepared from aromatic diamine, and preparation method
10/09/2013CN103342621A Method for performing catalytic synthesis of diphenylamine derivatives by using bisphenol copper salt
10/09/2013CN102584692B Preparation method of puridoxine hydrochloride
10/09/2013CN102532007B Method for preparing 2-chloro-5-substituted pyridine
10/09/2013CN102399181B Iridium coordination complex and preparation method thereof
10/09/2013CN102093150B Method for synthesizing aromatic amine
10/09/2013CN101801929B Method for producing 2,2-difluoroethylamine derivatives by amide hydrogenation
10/08/2013US8554373 Preparation and use of alkylating agents
10/08/2013US8552201 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
10/08/2013US8552200 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
10/08/2013US8552187 Processes and intermediates for carbamoylpyridone HIV integrase inhibitors
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/08/2013US8552036 Polymorph of atazanavir sulfate
10/08/2013US8552035 Phenanthrenone compounds, compositions and methods
10/08/2013US8552031 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
10/08/2013US8551445 Preparation and use of alkylating agents
10/08/2013CA2473938C Human adam-10 inhibitors
10/08/2013CA2359244C .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
10/03/2013WO2013148338A1 Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines
10/03/2013WO2013147216A1 (2-heteroarylamino)succinic acid derivative
10/03/2013WO2013146437A1 3-decenoic acid derivative and use for same
10/03/2013WO2013144977A2 An improved process for the preparation of etoricoxib
10/03/2013WO2013144213A1 N-substituted pyridinylidene compounds and derivatives for combating animal pests
10/03/2013WO2013144191A1 Substituted 2-amino-3-cyanopyridines as inhibitors of sodium-calcium exchange and use thereof for cardiovascular diseases
10/03/2013WO2013144180A1 Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
10/03/2013WO2013144179A1 Heteroaryl compounds with a-cyclic bridging unit
10/03/2013WO2013143811A1 N-cyclylamides as nematicides
10/03/2013WO2013143597A1 Demethylase enzymes inhibitors
10/03/2013WO2013143477A1 1,4-dihydroxy-6-methyl-2-pyridone compound, and preparation method and application thereof
10/03/2013US20130261310 Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines
10/03/2013US20130261309 Process for Preparing Alkali Metal Pyrithione and its Polyvalent Metal Complexes from Pyridine Oxide
10/03/2013US20130261295 Highly Active Multidentate Catalysts for Efficient Alkyne Metathesis
10/03/2013US20130261133 Therapeutic Compounds for Protozoal and Microbial Infections and Cancer
10/03/2013US20130261122 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261120 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
10/02/2013EP2644618A1 tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
10/02/2013EP2644595A1 N-Cyclylamides as nematicides
10/02/2013EP2643687A1 Improved planar chromatography
10/02/2013EP2643686A1 Planar chromatography with an inverse gradient elution
10/02/2013EP2643301A1 Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours
10/02/2013EP2643300A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013EP1944308B1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand
10/02/2013CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
10/02/2013CN103339104A Decahydro-1,4-methanonaphthalen carboxamides
10/02/2013CN103333157A Pyridine carboxamide derivative as kinase inhibitor
10/02/2013CN103333104A Preparation and synthesis method of 2-benzamides pyridinium acetate
10/02/2013CN103333103A Method for preparing flupirtine maleate by one-pot method
10/02/2013CN103333102A Pyridyl-N-cyano sulfo oxime compound and preparation method thereof
10/02/2013CN103333101A Pyridyl sulfoximine compound and preparation method thereof
10/02/2013CN102690228B Pyridine structure containing benzphenanthrene compound as well as preparation method and applications thereof
10/02/2013CN102458402B Nicotinamide compounds useful as kinase modulators
10/02/2013CN102149683B 1-(substituted benzyl)-5-trifluoromethyl-2-(1H) pyridone compounds and their salts, their preparation methods and use thereof
10/02/2013CN101808986B Imidate compound and use thereof for pest control
10/01/2013US8546579 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
10/01/2013US8546577 Substituted enaminocarbonyl compounds
10/01/2013US8546569 Chemical compounds
10/01/2013US8546563 Compounds which modulate the CB2 receptor
10/01/2013US8546416 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
10/01/2013US8546415 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546396 N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators
10/01/2013CA2681545C Fluorinated derivatives of deferiprone
10/01/2013CA2594508C Cyanoguanidine compounds
10/01/2013CA2594384C Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
10/01/2013CA2589495C 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
10/01/2013CA2585775C Cationic ceramides, and analogs thereof, and their use for preventing or treating cancer
10/01/2013CA2541989C P70s6 kinase modulators and method of use
09/2013
09/26/2013WO2013141097A1 Transparent electrode, electronic device, and organic electroluminescent element
09/26/2013WO2013141057A1 Organic electroluminescence element
09/26/2013WO2013139341A1 Gpr120 receptor modulators
09/26/2013US20130253142 Separating agent for protein purification and protein purification method
09/26/2013US20130253004 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
09/26/2013US20130252986 Compounds
09/26/2013US20130252984 Sulfur derivatives as chemokine receptor modulators
09/26/2013US20130252975 Novel rock inhibitors
09/26/2013US20130252974 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists
09/26/2013US20130252957 Pyridinone antagonists of alpha-4 integrins
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 633